Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share News
  5. LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

Pin to quick picksAstrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

Tue, 15th Nov 2022 09:58

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

Credit Suisse cuts B&M European Value Retail price target to 370 (460) pence - 'neutral'

----------

HSBC raises B&M price target to 495 (480) pence - 'buy'

----------

RBC raises B&M price target to 400 (360) pence - 'sector perform'

----------

LBBW raises AstraZeneca price target to 12,000 (11,500) pence - 'buy'

----------

Stifel raises AstraZeneca price target to 13,300 (12,300) pence - 'buy'

----------

Shore Capital raises Informa to 'buy' (hold)

----------

UBS raises Informa price target to 683 (654) pence - 'buy'

----------

Barclays raises Informa price target to 700 (685) pence - 'overweight'

----------

JPMorgan raises Informa price target to 650 (640) pence - 'neutral'

----------

Credit Suisse raises Informa price target to 740 (735) pence - 'outperform'

----------

Stifel raises GSK price target to 1,630 (1,600) pence - 'hold'

----------

RBC raises AB Foods price target to 1,600 (1,400) pence - 'sector perform'

----------

Liberum initiates Smith & Nephew with 'hold' - target 1120 pence

----------

Liberum initiates ConvaTec with 'buy' - target 265 pence

----------

FTSE 250

----------

Credit Suisse starts Hikma Pharmaceuticals with 'outperform' - price target 1,700 pence

----------

JPMorgan raises Vesuvius price target to 425 (415) pence - 'neutral'

----------

RBC raises Marks & Spencer price target to 125 (105) pence - 'sector perform'

----------

RBC cuts Drax price target to 950 (1,175) pence - 'outperform'

----------

JPMorgan cuts Moonpig price target to 320 (460) pence - 'overweight'

----------

Jefferies cuts Aston Martin to 'underperform' (hold) - price target 120 (530) pence

----------

SMALL CAP

----------

Credit Suisse raises S4 Capital price target to 295 pence - 'outperform'

----------

Citigroup cuts S4 Capital price target to 390 (415) pence - 'buy'

----------

HSBC cuts Nichols price target to 1,100 (1,220) pence - 'hold'

----------

Jefferies cuts ITM Power to 'hold' (buy) - price target 105 (185) pence

----------

Liberum resumes Renewi with 'buy' - target 865 pence

----------

Liberum initiates Advanced Medical Solutions with 'buy' - target 339 pence

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.